Importantly, patients with combined NANOG+/HSP90A+ level was strongly associated with large-sized tumor (Fig. 3e and Supplementary Fig. 8) and chemo-radiation resistance (Fig. 3f and Supplementary Fig. 9) than those with NANOG−/HSP90A− level. This evidence concerns the gene NANOG and neoplasm.